No Data
No Data
Evolent Health Price Target Cut to $18.00/Share From $27.00 by JMP Securities
Evolent Health Is Maintained at Market Outperform by JMP Securities
Citi Maintains Evolent Health(EVH.US) With Buy Rating, Cuts Target Price to $18
Needham Initiates Coverage On Evolent Health With Buy Rating, Announces Price Target of $15
Evolent Health Analyst Ratings
Express News | Evolent Health Inc : Needham Initiates Coverage With Buy Rating; Target Price $15
ProperMicheleV : I like the way you're thinking. thanks for the information. I've worked for value based care organizations & I'm not sure if VBC is the answer. I believe the answer to reducing health care costs starts with farm subsidies. most of the patients I work with are people of color who have been economically marginalized for generations. they have to buy shitty cheap food to feed the family. mostly corn based products bc corn is heavily subsidized. diabetes, chronic kidney disease, hypertension, chronic heart failure, the list goes on. polychronic conditions are the new normal & companies like uhc love that. Just remember we are all in this together. I'm happy to make less money trading if it means my fellow humans are well.
Tinkering : Thank you for this research.
Personally, I will be looking into them and others for the same reasons you are.